ILMN vs NDRA · rev $4.34B vs P/E 0.0, $2.6M cap
Illumina Inc (ILMN) versus ENDRA Life Sciences Inc (NDRA) — a side-by-side from cached financials, not a winner call.
Illumina Inc (ILMN) is a diagnostics & research company listed on US.
ENDRA Life Sciences Inc (NDRA) is a diagnostics & research company listed on US.
Latest reported ILMN revenue for 2025-12-28 was $4.34B. Net income was $850.0M. Revenue was down 0.7% from 2024-12-29 to 2025-12-28. ILMN currently screens at market cap $15.84B.
NDRA does not have a complete income-statement cache yet.
ILMN currently screens at market cap $15.84B. NDRA currently screens at market cap $2.6M and trailing P/E 0.0.
Not investment advice. Open the ILMN and NDRA stock pages for the full models.
Not investment advice.